# To Assess the Safety and Efficacy of Travacom in Patients With Uncontrolled Intraocular Pressure

> **NCT01159756** · PHASE4 · COMPLETED · sponsor: **Alcon Research** · enrollment: 468 (actual)

## Conditions studied

- Uncontrolled Intraocular Pressure

## Interventions

- **DRUG:** Travacom

## Key facts

- **NCT ID:** NCT01159756
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 468 (ACTUAL)
- **Last updated:** 2012-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01159756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01159756, "To Assess the Safety and Efficacy of Travacom in Patients With Uncontrolled Intraocular Pressure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01159756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*